Related Experiment Video
Updated: Jul 11, 2026

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
Published on: August 8, 2014
Chronic infections and atherosclerosis
Kiyoshi Ayada1, Kenji Yokota, Kazuko Kobayashi
1Department of Bacteriology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.
Chronic Helicobacter pylori infection promotes atherosclerosis in mice through autoimmunity against heat shock protein 60 (HSP60). Targeting HSP60-specific immune responses may reduce atherosclerosis progression.
Area of Science:
- Immunology
- Cardiovascular Science
- Microbiology
Background:
- Chronic infections and immunoinflammatory processes are linked to atherosclerosis development.
- Anti-heat shock protein (HSP) antibodies and HSP60-specific T lymphocytes are associated with increased atherosclerosis risk.
- Helicobacter pylori (H. pylori) infection is implicated in cardiovascular diseases.
Purpose of the Study:
- To investigate the role of H. pylori infection in atherosclerosis progression.
- To explore the involvement of anti-HSP immune responses in H. pylori-induced atherosclerosis.
- To evaluate potential therapeutic strategies targeting HSP60-specific immunity.
Main Methods:
- Utilized apoe+/- ldlr+/- mouse models to study atherosclerosis.
- Induced H. pylori infection and monitored atherosclerosis development.
- Assessed Th1-dominant immune responses specific to H. pylori-derived HSP.
- Investigated molecular mimicry between bacterial and endogenous HSP60.
Main Results:
- H. pylori infection significantly accelerated atherosclerosis in the studied mouse model.
- Hp-anti-HSP specific Th1 immune responses were crucial for atherosclerosis progression.
- Evidence of autoimmunity against endogenous HSP60 on vascular endothelium was observed due to molecular mimicry.
- Reduced atherosclerosis progression was noted with interventions regulating Th1 induction.
Conclusions:
- H. pylori infection can induce atherosclerosis via autoimmune responses against HSP60.
- Molecular mimicry between H. pylori HSP and human HSP60 plays a key role.
- Antibiotic treatment or anti-HSP60 antibody therapy may offer a strategy to mitigate atherosclerosis progression.
Related Concept Videos
Atherosclerosis I: Introduction
Chronic Inflammation: Introduction
Inflammation
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
